PROJECT CONCEPT

Most toxins present in animal venoms are small proteins (peptides) that show great promise as innovative drugs. They combine higher potency and lower side effects than small molecules due to their increased efficiency and target selectivity.

Venom peptides offer the potential to improve the drug arsenal available to treat a range of therapeutic conditions such as pain or cancer where medical needs are not properly addressed by the current pharmacopoeia.

The core objective of the VENOMICS project is to recreate in vitro collections of venom peptides that can be used as a resource for high-throughput screening to more efficiently isolate novel drug leads. This approach is akin to re-creating "synthetic venoms" in the laboratory.



FP7 Logo


FP7 Logo